Table 2 Baseline and post-treatment CD11b expression levels in primary samples from 7 AML patients
From: Repositioning of bromocriptine for treatment of acute myeloid leukemia
AML sample | Vehicle control treatment | Bromocriptine treatment | CD11b induction | ||
|---|---|---|---|---|---|
Mean | SEM | Mean | SEM | ||
#2 | 0.78 | 0.09 | 8.31 | 2.73 | 10.65 |
#4 | 0.82 | 0.49 | 5.00 | 1.90 | 6.10 |
#5 | 3.94 | 1.59 | 19.31 | 8.24 | 4.90 |
#8 | 3.25 | 0.20 | 14.81 | 11.45 | 4.56 |
#10 | 8.48 | 0.18 | 6.38 | 2.03 | 0.75 |
#14 | 3.37 | 0.14 | 34.02 | 0.95 | 10.09 |
#22 | 21.43 | 0.74 | 30.90 | 0.78 | 1.44 |